Sydney, Australia (CU)_ Illuccix, a prostate cancer imaging tool developed by Telix Pharmaceuticals (TLX), has been authorized by the US Food and Drug Administration. The product is a kit for making an…

FDA approves Telix Pharmaceuticals’ prostate cancer treatment

Global Economic Briefing – 26 February 2026

Escape the Ordinary: Discover Malaysia’s Hidden Wellness Paradise

Western Cape Provincial Government Denounces Fatal Taxi Conflict in Atlantis

Rejuvenate in Royal Style: Exploring Wellness Tourism in the United Kingdom

UK Foreign Office Denies Minister’s Claim That Chagos Islands Deal Has Been Paused

Related Articles

The Surprising Link Between Kids’ Meals and Brain Health

Could One Vaccine Protect You From Many Colds, flus, and Allergies?

Could This New Gel Save Millions from Serious Wounds?

New Zealand Neurology Crisis: One Specialist per 74,000 People as Disease Burden Grows

Are ‘Dancing Molecules’ the Future of Spinal Cord Injury Treatment? Human Organoid Study Offers Strong Evidence

BRICS expansion: five countries join, another 25 to follow in 2024

Chinese state media lauds India’s achievements under PM Modi!

Security alarm for India: Bangladesh frees Al-Qaeda terror group chief